The Governor of Missouri has announced the largest single investment in anti-smoking efforts in the state's history, earning praise from the largest healthcare system in central Missouri.
On August 3, 2022, Don Young, who became mute due to smoking, shared his story with Governor Mike Parson and others. The photo was provided by the governor's Flickr page.
MU Health, headquartered in Columbia, has announced that this move will save Missouri $21 million in healthcare costs. Dr. Kevin Everett, Associate Professor of Family and Community Medicine, expressed excitement about the announcement to 939 the Eagle, stating that "this is a great start. We really need this in Missouri where smoking rates are high and young people are using e-cigarette products. It will be very important to develop cessation programs and access for people.
The Center for Disease Control stated that the use of e-cigarettes poses a safety hazard to children, adolescents, and young adults. Governor Parson announced that $2.5 million will be allocated towards a smoking cessation program, with an initial funding of only $50,000.
Meanwhile, a man from Missouri named Don Young has been left mute due to smoking. He claims to have received thousands of letters, and his story has inspired people to quit smoking. Young spoke at a press conference held by the governor of Columbia, and the room fell silent as he used a machine to communicate.
Everett stated that Don Young's story is very persuasive.
According to Dr. Everett, Don Young leads a difficult and inescapable life, but he is a great advocate for raising awareness about the dangers of smoking.
The Governor stated that the smoking cessation program aims to protect minors from the harmful effects of illegal tobacco sales. Governor Parson noted that tobacco is the leading cause of illness and premature death in Missouri, with 11,000 deaths attributed to smoking each year in the state.
Statement:
This article is compiled from third-party information and intended for industry professionals for communication and learning purposes.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness and accuracy of the article's content. The compilation of this article is only intended for industry exchange and research.
Due to limitations in the level of translation, the translated article may not fully reflect the original text. Please refer to the original text for accuracy.
2FIRSTS aligns completely with the position and statements of the Chinese government regarding matters concerning domestic issues, as well as those involving Hong Kong, Macau, Taiwan, and foreign relations.
The compiled information is subject to the copyright of the original media and authors. If there are any infringements, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
